Fatal Primary Amebic Meningoencephalitis due to Naegleria fowleri: The First Imported Case in Korea
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Primary amebic meningoencephalitis (PAM) is a rare, but almost always fatal, central nervous system infection caused by Naegle ria fowleri, which are thermophilic free-living amoeba. Here, we report the first case of PAM detected in South Korea, probably imported from Thailand. Despite antimicrobial treatment for N. fowleri infection with a combination of intravenous liposomal amphotericin B, fluconazole, azithromycin, and oral rifampin, the patient died 13 days after the onset of symptoms. Clinicians in South Korea treating severe meningoencephalitis, especially in individuals returning from tropical areas, are encouraged to in clude PAM in the differential diagnoses, given the accelerated global warming and increased overseas trips.
Abstract
Primary amebic meningoencephalitis (PAM) is a rare, but almost always fatal, central nervous system infection caused by Naegle ria fowleri, which are thermophilic free-living amoeba. Here, we report the first case of PAM detected in South Korea, probably imported from Thailand. Despite antimicrobial treatment for N. fowleri infection with a combination of intravenous liposomal amphotericin B, fluconazole, azithromycin, and oral rifampin, the patient died 13 days after the onset of symptoms. Clinicians in South Korea treating severe meningoencephalitis, especially in individuals returning from tropical areas, are encouraged to in clude PAM in the differential diagnoses, given the accelerated global warming and increased overseas trips.
참고문헌 (18)
- Gharpure R, "Epidemiology and clinical characteristics of primary amebic meningoencephalitis caused by Naegleria fowleri : a global review", Clin Infect Dis, 73, pp.e19~e27 (2021)
- 김민정, "Surveillance of viable Acanthamoeba spp. and Naegleria fowleri in major water sources for tap water in Korea", 미생물학회지, 54(3), pp.237~243 (2018), 한국미생물학회[DOI]
- "Korea tourism statistics"[URL]
- Bellini NK, "The therapeutic strategies against Naegleria fowleri", Exp Parasitol, 187, pp.1~11 (2018)
- Ghanchi NK, "Case series of Naegleria fowleri primary ameobic meningoencephalitis from Karachi, Pakistan", Am J Trop Med Hyg, 97, pp.1600~1602 (2017)
- Carter RF, "Sensitivity to amphotericin B of a Naegleria sp. isolated from a case of primary amoebic meningoencephalitis", J Clin Pathol, 22, pp.470~474 (1969)
- Schuster FL, "In vitro effects of amphotericin B on growth and ultrastructure of the amoeboflagellates Naegleria gruberi and Naegleria fowleri", Antimicrob Agents Chemother, 8, pp.591~605 (1975)
- Goswick SM, "Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis", Antimicrob Agents Chemother, 47, pp.524~528 (2003)
- Grace E, "Naegleria fowleri : pathogenesis, diagnosis, and treatment options", Antimicrob Agents Chemother, 59, pp.6677~6681 (2015)
- Capewell LG, "Diagnosis, clinical course, and treatment of primary amoebic meningoencephalitis in the United States, 1937-2013", J Pediatric Infect Dis Soc, 4, pp.e68~e75 (2015)
- Kim JH, "Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri", Antimicrob Agents Chemother, 52, pp.4010~4016 (2008)
- "Naegleria fowleri -primary amebic meningoencephalitis (PAM) - amebic encephalitis"[URL]
- Soltow SM, "Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis", Antimicrob Agents Chemother, 51, pp.23~27 (2007)
- Anderson K, "Primary amoebic meningoencephalitis", Lancet, 1, pp.902~903 (1972)
- Seidel JS, "Successful treatment of primary amebic meningoencephalitis", N Engl J Med, 306, pp.346~348 (1982)
- Vargas-Zepeda J, "Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin", Arch Med Res, 36, pp.83~86 (2005)
- Linam WM, "Successful treatment of an adolescent with Naegleria fowleri primary amebic meningoencephalitis", Pediatrics, 135, pp.e744~e748 (2015)
- Cope JR, "Use of the novel therapeutic agent miltefosine for the treatment of primary amebic meningoencephalitis : report of 1 fatal and 1 surviving case", Clin Infect Dis, 62, pp.774~776 (2016)